CD69 and melanoma: In co-culture with two melanoma cell lines, ME4405 and SK-MEL-28 (which harbor BRAF and NRAS mutations, respectively), we observed that knockdown of CCNB1 in melanoma cells increased the proportion of NK-92MI expressing CD69 and CD107a (Figure 5B,C), which are key markers of NK cell activation.